Skip to main content
Explore URMC
menu

Jane Larae Liesveld, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-5823

Administrative: (585) 275-4099

Office: (585) 275-5823

Fax: (585) 273-1051

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Settings

Cancer, Hospital Medicine

Biography

While the doctor-patient relationship is one of potential intensity and privacy, the best patient care comes from teamwork, which values all who contribute to achieving high-quality care with compassion. Providing patients and their families with the knowledge and means to be partners in care is one of my key roles as a physician.

When a patient is diagnosed with a blood cancer or chronic blood condition, it is often the start of a new journey that will be the beginning of great change. Walking with patients through this journey from start to finish, and offering therapy and guidance along the way, is a source of professional and personal satisfaction for me. Hematology/oncology is a field where clinical and basic research can be rapidly applied to improve outcomes and quality of life.

I grew up in the Midwest, but have lived in Rochester since I began my post-doctoral medical training. My association with Strong, the University of Rochester and the people in our community and surrounding areas has enriched my life. I feel privileged to work in such a wonderful environment. I have expertise in novel therapies for acute myeloid leukemia, stem cell mobilization and homing, as well as stem cell transplantation.

Conditions I Treat

- Leukemia, all types
- Myeloproliferative disorders
- Myelodysplastic syndromes
- Multiple myeloma
- Stem cell transplantation

Research

Effects of oxygen metabolites/chemokines on hematopoietic stem cell expansion and preservation.

Effects of hematopoietic growth factors and inhibitors on AML blast proliferation (correlative clinical studies)

Effects of hematopoietic stem cell adhesion on marrow stromal cell cytokine production.

Role of signal transduction inhibition in treatment of acute myelogenous leukemia/myelodysplasia.

Characterization of mobilized peripheral blood stem cells

Credentials

Education

1980
MD | University Of Iowa Roy J & Lucille A Carver College Of Medicine

Post-doctoral Training & Residency

07/01/1988 - 06/30/1989
Fellowship at University of Rochester Medical Center

07/01/1987 - 06/30/1988
Fellowship at University of Rochester Medical Center

07/01/1984 - 06/30/1987
Fellowship in Hematology at University of Rochester Medical Center

07/01/1981 - 06/30/1984
Residency in Internal Medicine at University of Rochester Medical Center

07/01/1980 - 06/30/1981
Internship in Internal Medicine at University of Rochester Medical Center

VIEW ALL expand_more

Awards

2009
Gilda's Club of Rochester Jacob Gitelman Award

2007
Hematology-Oncology Fellowship Teaching Award

2005 - 2007
Aplastic Anemia and MDS International Foundation Gordon Forgash Research Award

2004 - 2006
Lawrence A. Kohn Senior Teaching Fellowship
Sponsor: University of Rochester Department of Medicine

1998 - 2003
Leukemia Society of America, Clinical Scholar Award

1989 - 1992
Leukemia Society of America Special Fellowship

1989 - 1992
James P. Wilmot Postdoctoral Cancer Research Fellowship

1987 - 1988
American Cancer Society Clinical Fellowship Award

VIEW ALL expand_more

Patents

Patent Title: Continuous Flow Chamber Device for Separation, Concentration and/or Purification of Cells
Patent #: 7,892,766
Issue Date: Feb 22, 2011
Country: United States
Invented By: Nichola Charles, Nathan Clark, John P Gentile, Michael R King, Jane Liesveld, Nipa Anand Mody

Publications

Journal Articles

8/12/2023
Stein EM, de Botton S, Cluzeau T, Pigneux A, Liesveld JL, Cook RJ, Rousselot P, Rizzieri DA, Braun T, Roboz GJ, Lebon D, Heiblig M, Baker K, Volkert A, Paul S, Rajagopal N, Roth DA, Kelly M, Peterlin P. "Use of tamibarotene, a potent and selective RAR? agonist, in combination with azacitidine in patients with relapsed and refractory AML with gene overexpression." Leukemia & lymphoma.. 2023 Aug 12; :1-10. Epub 2023 Aug 12.

7/14/2023
Quarato ER, Salama NA, Li AJ, Smith CO, Zhang J, Kawano Y, McArthur M, Liesveld JL, Becker MW, Elliott MR, Eliseev RA, Calvi LM. "Efferocytosis by bone marrow mesenchymal stromal cells disrupts osteoblastic differentiation via mitochondrial remodeling." Cell death & disease.. 2023 Jul 14; 14(7):428. Epub 2023 Jul 14.

5/3/2023
Tamari R, McLornan DP, Ahn KW, Estrada-Merly N, Hernandez-Boluda JC, Giralt SA, Palmer JM, Gale RP, DeFilipp Z, Marks D, van der Poel MWM, Verdonck LF, Battiwalla M, Díaz MA, Gupta V, Ali H, Litzow MR, Lazarus HM, Gergis U, Bashey A, Liesveld JL, Hashmi S, Pu JJ, Beitinjaneh A, Bredeson CN, Rizzieri DA, Savani BN, Abid MB, Ganguly S, Agrawal V, Ulrike V, Wirk B, Jain T, Cutler CS, Aljurf M, Kindwall-Keller T, Kharfan-Dabaja MA, Hildebrandt GC, Pawarode A, Solh MM, Yared JA, Grunwald MR, Nathan S, Nishihori T, Seo S, Scott BL, Nakamura R, Oran B, Czerw T, Yakoub-Agha I, Saber W. "A Simple Prognostic System in Myelofibrosis Patients Undergoing Allogeneic Stem Cell Transplant: A CIBMTR/EBMT analysis." Blood advances.. 2023 May 3; Epub 2023 May 03.

Books & Chapters

2017
Chapter Title: Stem Cell Mobilization
Book Title: In: Encyclopedia of Cancer
Author List: Liesveld, JL
Edited By: Schwab, M
Published By: Springer-Verlag 2017

2016
Chapter Title: Chronic Myelogenous Leukemia and Related Disorders
Book Title: In: Williams Hematology
Author List: Liesveld, JL and Lichtman, MA
Edited By: Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, Burns LJ, Caligiuri MA,
Published By: McGraw Hill 2016 in New York, NY

2016
Chapter Title: Acute Myelogenous Leukemia
Book Title: In: Williams Hematology
Author List: Liesveld, JL and Lichtman, MA
Edited By: Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, Burns LJ, Caligiuri MA
Published By: McGraw Hill 2016 in New York, NY

VIEW ALL PUBLICATIONS

Videos

play_circle_filled

SECOND OPINION | Leukemia (CLL) | APT

play_circle_filled

SECOND OPINION | Leukemia (CLL) | APT | Full Episode